A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bina Tejura, MD
Seres Therapeutics, Inc.
Study Director - Doris Ponce, MD
MSKCC
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Banner Health - Md Anderson Medical Center
Gilbert, Arizona, United States
- Mayo Clinic - Scottsdale
Scottsdale, Arizona, United States
- City of Hope
Duarte, California, United States
- University of California, Los Angeles - Division of Hematology-Oncology
Marina del Rey, California, United States
- Georgetown (medstar Health)
Washington D.C., District of Columbia, United States
- University of Florida - Division of Hematology & Oncology
Gainesville, Florida, United States
- Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
- University of Chicago Medical Center
Chicago, Illinois, United States
- Harvard Medical School - Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- Mayo Clinic - Rochester
Rochester, Minnesota, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- University of North Carolina Chapel Hill
Chapel Hill, North Carolina, United States
- Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Nov 2021
- Primary completion
- 23 Jul 2024
- Completion
- 23 Jul 2024
- Last update posted
- 1 Oct 2024
- Registered enrollment
- 60
- Registry id
- NCT04995653
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.